1-20 of 166
Yan Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT553: Tislelizumab (TIS) versus docetaxel (D) in patients with previously treated advanced non-squamous (non-sq) non-small-cell lung cancer (NSCLC): Subanalysis from the RATIONALE-303 phase 3 randomized clinical study

Ying Cheng, Dingzhi Huang, Zhiyong Ma, Yun Fan, Jie Wang, Xinmin Yu, Mikhail Dvorkin, Gareth Rivalland, Yiyuan Ma, Yan Wang, Yan Ma, Caicun Zhou
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT553.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT553
Published: 15 June 2022
View article
Journal Articles

Abstract CT554: Tislelizumab (TIS) versus docetaxel (D) in patients with previously treated advanced squamous (sq) non-small-cell lung cancer (NSCLC): Sub-analysis from phase 3 RATIONALE-303 randomized clinical study

Jie Wang, Zhiyong Ma, Dingzhi Huang, Yun Fan, Xinmin Yu, Sheng Hu, Ziping Wang, Zhihua Liu, Devrim Cabuk, Mahmut Gumus, Yiyuan Ma, Yan Wang, Yan Ma, Caicun Zhou
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT554.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT554
Published: 15 June 2022
View article
Journal Articles

Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors

Peirong Chen, Suzanne C. Crawley, Vicky Y. Lin, Varun Kapoor, Kevin J. Paavola, Hung-I Chen, Joshua S. Lichtman, Betty Li, Kalyani Mondal, Alan K. Kutach, Yan Wang, Daniel D. Kaplan, Julie M. Roda
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB216.
DOI: https://doi.org/10.1158/1538-7445.AM2022-LB216
Published: 15 June 2022
View article
Journal Articles

Abstract LB219: Preclinical development of NGM438, a novel anti-LAIR1 antagonist monoclonal antibody for the treatment of collagen-rich solid tumors

Sisi He, Jiawei Huang, Leticia Rodriguez, Czrina Cortez, Betty Li, Carmence Ho, Amir Ashique, Kalyani Mondal, Vicky Lin, Julie Roda, Hui Tian, Yan Wang, Bin Fan, Igor Mikaelian, James Sissons, Lee Rivera, Don Gibbons, Jonathan Sitrin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB219.
DOI: https://doi.org/10.1158/1538-7445.AM2022-LB219
Published: 15 June 2022
View article
Journal Articles

Abstract CT513: Phase I study of IBI322 (anti-CD47/PD-L1 bispecific antibody) monotherapy therapy in patients with advanced solid tumors in China

Jie Wang, Yuping Sun, Qian Chu, Jianchun Duan, Rui Wan, Zhijie Wang, Jun Zhao, Haoyuan Li, Yingmei Guo, Yuling Chen, Yan Wang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT513.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT513
Published: 15 June 2022
View article
Journal Articles

Abstract 1268: Early proliferative response via [18]FLT-PET/CT and serum TK1 activity are predictive biomarkers for synergistic effect of sequential cell cycle targeted therapy in sarcoma

Tuyen Duong Nguyen, Marc A. Pina, Yan Wang, Cansu Karakas, Tuyen N. Bui, Osama Mawlawi, Alexander J. Lazar, Davis R. Ingram, Peter J. Hougton, Kelly K. Hunt, Khandan Keyomarsi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1268.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1268
Published: 15 June 2022
View article
Journal Articles

Abstract 2592: Aurora kinase is an actionable target in low molecular weight cyclin E induced mammary tumors

Said Akli, Amriti R. Lulla, Francisco R. Saenz, Fuchenchu Wang, Natalie W. Fowlkes, Tuyen Bui, Yan Wang, Sofia Mastoraki, Min Jin Ha, Kelly K. Hunt, Khandan Keyomarsi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2592.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2592
Published: 15 June 2022
View article
Journal Articles

Abstract 664: Immune inhibitory receptors ILT2 and ILT4 exhibit both distinct and overlapping biology in vitro and in vivo

Jane Tian, Samir Qurashi, Christina Song, Lauren Rocha, Kalyani Mondal, Suzanne Crawley, Sara Medfisch, Peirong Krisney Chen, Julie Roda, Jon Sitrin, Carmence Ho, Jonathan Aguayo, Lee Rivera, Jiawei Huang, Vicky Lin, David Shen, Yan Wang, Hui Tian, Alan Kutach, James Sissons, Daniel D. Kaplan, Geoffrey W. Stone
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 664.
DOI: https://doi.org/10.1158/1538-7445.AM2022-664
Published: 15 June 2022
View article
Journal Articles

Abstract 5690: The landscape of homologous recombination repair gene mutations and prognosis in Chinese patients with clear cell renal cell carcinoma

Peng Chen, Yuan Zhang, Xing Bi, Yue Niu, Fuerhaiti Shayiti, Shuai Yuan, Ting Pan, Yan Wang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5690.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5690
Published: 15 June 2022
View article
Journal Articles

Abstract 6175: Developing antibody-drug conjugates against cholangiocarcinoma using a novel molecular target

Bing Zhu, Shi-Li Yao, Xin-Yan Wang, Rui Xu, Peng Guo, Jie-Er Ying
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6175.
DOI: https://doi.org/10.1158/1538-7445.AM2022-6175
Published: 15 June 2022
View article
Journal Articles

Abstract LB023: Thyroid hormone receptor signaling promotes antiandrogen resistance and bone metastasis in prostate cancer

Yan Wang, Gurrapu Harsha, Dhiraj Kumar, Josue Curto, Xiaobo Wang, Filippo Giancotti
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB023.
DOI: https://doi.org/10.1158/1538-7445.AM2022-LB023
Published: 15 June 2022
View article
Journal Articles

Abstract 2660: The gene mutation profile in HCC patients with different AFP levels at diagnosis

Xiang Kui, Liqun Wu, Yang Ke, Yan Wang, Hai Li, Juan Zhao, Tingting He, Lin Wang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2660.
DOI: https://doi.org/10.1158/1538-7445.AM2021-2660
Published: 01 July 2021
View article
Journal Articles

Abstract CT039: Results from RATIONALE 303: A global phase 3 study of tislelizumab (TIS) vs docetaxel (TAX) as second- or third-line therapy for patients with locally advanced or metastatic NSCLC

Caicun Zhou, Dingzhi Huang, Xinmin Yu, Yunpeng Liu, Yun Fan, Yongqian Shu, Zhiyong Ma, Ziping Wang, Ying Cheng, Jie Wang, Sheng Hu, Zhihua Liu, Mikhail Dvorkin, Elena Poddubskaya, Umut Disel, Andrey Akopov, Yiyuan Ma, Yan Wang, Zhenyu Pan, Cunjing Yu, Gareth Rivalland
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT039.
DOI: https://doi.org/10.1158/1538-7445.AM2021-CT039
Published: 01 July 2021
View article
Journal Articles

Abstract CT041: ORIENT-3: A randomized, open-label, phase 3 study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small-cell lung cancer (sqNSCLC)

Yuankai Shi, Lin Wu, Xinmin Yu, Yan Wang, Puyuan Xing, Jianying Zhou, Airong Wang, Jianhua Shi, Yi Hu, Ziping Wang, Guangyu An, Yong Fang, Sanyuan Sun, Caicun Zhou, Changli Wang, Feng Ye, Xingya Li, Junye Wang, Mengzhao Wang, Yunpeng Liu, Yanqiu Zhao, Jifeng Feng
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT041.
DOI: https://doi.org/10.1158/1538-7445.AM2021-CT041
Published: 01 July 2021
View article
Journal Articles

Abstract 2206: Investigation of DNA damage repair mutated characteristics and correlation with immunogenic biomarker in Chinese head and neck cancer patients

Yong Chen, Yan Wang, Yating Zheng, Wenzhuan Xie, Mengli Huang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2206.
DOI: https://doi.org/10.1158/1538-7445.AM2021-2206
Published: 01 July 2021
View article
Journal Articles

Abstract LB156: Preclinical evaluation of NGM707, a novel anti-ILT2/anti-ILT4 dual antagonist monoclonal antibody

Kalyani Mondal, Christina Song, Jane Tian, Carmence Ho, Lee B. Rivera, Jiawei Huang, Peirong Chen, Suzanne Crawley, Vicky Y. Lin, Jonathan Sitrin, Julie M. Roda, David Shen, Hui Tian, Yan Wang, Alan Kutach, Jeong Kim, James Sissons, Daniel D. Kaplan, Geoffrey W. Stone
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB156.
DOI: https://doi.org/10.1158/1538-7445.AM2021-LB156
Published: 01 July 2021
View article
Journal Articles

Long Noncoding RNA VESTAR Regulates Lymphangiogenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma by Enhancing VEGFC mRNA Stability

Yali Wang, Weimin Zhang, Wenzhong Liu, Lijie Huang, Yan Wang, Dan Li, Guangchao Wang, Zitong Zhao, Xinming Chi, Yu Xue, Yongmei Song, Xuefeng Liu, Qimin Zhan
Journal: Cancer Research
Cancer Res (2021) 81 (12): 3187–3199.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-1713
Published: 15 June 2021
View article
PDF
Includes: Supplementary data
Journal Articles

LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells

Shujun Han, Yuwei Yan, Yibo Ren, Yiming Hu, Yan Wang, Lei Chen, Zhe Zhi, Yan Zheng, Yongping Shao, Jiankang Liu
Journal: Cancer Research
Cancer Res (2021) 81 (11): 2918–2929.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-3145
Published: 01 June 2021
View article
PDF
Includes: Supplementary data
Journal Articles

A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression

Dezuo Dong, Weimin Zhang, Wenchang Xiao, Qingnan Wu, Yiren Cao, Xiaohan Gao, Lijie Huang, Yan Wang, Jie Chen, Weihu Wang, Qimin Zhan
Journal: Cancer Research
Cancer Res (2021) 81 (4): 910–922.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-0912
Published: 15 February 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract PS1-30: A prospective phase II trial to evaluate the feasibility of omit sentinel lymph node biopsy after integrate18F-FDG dedicated axillary PET in early breast cancer: SOAPET trial

Junjie Li, Jingyi Cheng, Guangyu Liu, Yifeng Hou, Genghong Di, Benlong Yang, Yizhou Jiang, Liang Huang, Sheng Chen, Yan Wang, Keda Yu, Zhimin Shao
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS1-30.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS1-30
Published: 15 February 2021
View article